Literature DB >> 26253340

Alteration of brainstem raphe measured by transcranial sonography in depression patients with or without Parkinson's disease.

Ying Chun Zhang1, Hua Hu2, Wei Feng Luo3, Yu Jing Sheng1, Xiao Fang Chen1, Cheng Jie Mao3, Kang Ping Xiong3, Li Fang Yu1, Ying Zhang1, Chun Feng Liu4.   

Abstract

The purpose of our study was to assess the alteration of the brainstem raphe (BR) on transcranial sonography (TCS) in depression patients with or without Parkinson's disease (PD) and to explore whether the different changes of BR could reflect an increasing impairment of raphe structures. TCS was performed in patients with PD, depression with PD, depression only, and controls. Using the red nucleus as an internal standard, the BR was rated semi-quantitatively from grades 1-4 with grades 1-3 determined as abnormal. The rate of abnormal BR (≤grade 3) was found to be only 10 % in patients with PD (4/40) and 5 % in control patients (2/40). The rate of abnormal raphe was significantly higher (p < 0.05) in patients with both depression and PD (85 %, 34/40) or patients with depression only (87.5 %, 35/40). TCS of the raphe in most patients with mild depression scored grade 3, while those with moderate depression scored grade 2-3, and those with severe depression scored grade 1. The different BR echogenicity score reflected an increasing impairment of raphe structures in depression patients with or without PD (p < 0.05). TCS provides a good tool for assessing depression, more severe depressive symptoms were associated with different aspects in TCS studies.

Entities:  

Keywords:  Brainstem raphe; Depression; Parkinson’s disease; Transcranial sonography

Mesh:

Year:  2015        PMID: 26253340     DOI: 10.1007/s10072-015-2350-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  Transcranial sonography on Parkinson's disease and essential tremor in a Chinese population.

Authors:  Wei-Feng Luo; Ying-Chun Zhang; Yu-Jing Sheng; Jun-Chu Fang; Chun-Feng Liu
Journal:  Neurol Sci       Date:  2011-12-11       Impact factor: 3.307

2.  Evaluation of basal ganglia, brainstem raphe and ventricles in bipolar disorder by transcranial sonography.

Authors:  Christos Krogias; Kija Hoffmann; Jens Eyding; Dirk Scheele; Christine Norra; Ralf Gold; Georg Juckel; Hans-Jörg Assion
Journal:  Psychiatry Res       Date:  2011-09-29       Impact factor: 3.222

3.  Transcranial sonography (TCS) in Parkinson's disease (PD) and essential tremor (ET) in relation with putative premotor symptoms of PD.

Authors:  Joong-Seok Kim; Yoon-Sang Oh; Yeong-In Kim; Ja-Seong Koo; Dong-Won Yang; Kwang-Soo Lee
Journal:  Arch Gerontol Geriatr       Date:  2012-01-25       Impact factor: 3.250

Review 4.  Transcranial brain parenchyma sonography in movement disorders: state of the art.

Authors:  Uwe Walter; Stefanie Behnke; Jens Eyding; Ludwig Niehaus; Thomas Postert; Günter Seidel; Daniela Berg
Journal:  Ultrasound Med Biol       Date:  2007-01       Impact factor: 2.998

Review 5.  Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies.

Authors:  U Walter; D Školoudík
Journal:  Ultraschall Med       Date:  2014-04-24       Impact factor: 6.548

6.  Echogenicity of the brainstem raphe in patients with major depression.

Authors:  G Becker; M Struck; U Bogdahn; T Becker
Journal:  Psychiatry Res       Date:  1994-06       Impact factor: 3.222

7.  Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography.

Authors:  T Becker; G Becker; J Seufert; E Hofmann; K W Lange; M Naumann; A Lindner; H Reichmann; P Riederer; H Beckmann; K Reiners
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

Review 8.  Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review.

Authors:  Agnieszka Dyduch; Maria Załuska
Journal:  Psychogeriatrics       Date:  2014-11-05       Impact factor: 2.440

Review 9.  Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings.

Authors:  G Becker; D Berg; K P Lesch; T Becker
Journal:  Int J Neuropsychopharmacol       Date:  2001-03       Impact factor: 5.176

10.  Brainstem raphe lesion in patients with major depressive disorder and in patients with suicidal ideation recorded on transcranial sonography.

Authors:  Mislav Budisic; Budisic Mislav; Dalibor Karlovic; Karlovic Dalibor; Zlatko Trkanjec; Trkanjec Zlatko; Arijana Lovrencic-Huzjan; Lovrencic-Huzjan Arijana; Vlasta Vukovic; Vukovic Vlasta; Jelena Bosnjak; Bosnjak Jelena; Vida Demarin; Demarin Vida
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-09-15       Impact factor: 5.270

View more
  4 in total

1.  Transcranial sonography image characteristics in different Parkinson's disease subtypes.

Authors:  Ai Yan Sheng; Ying Chun Zhang; Yu Jing Sheng; Cai Shan Wang; Ying Zhang; Hua Hu; Wei Feng Luo; CHun-Feng LIu
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

2.  Transcranial sonography findings related to depression in parkinsonian disorders: cross-sectional study in 126 patients.

Authors:  Angela E P Bouwmans; Wim E J Weber; Albert F G Leentjens; Werner H Mess
Journal:  PeerJ       Date:  2016-05-18       Impact factor: 2.984

3.  Echogenic alteration in the raphe nuclei measured by transcranial sonography in patients with Parkinson disease and depression.

Authors:  Xue Jiao Liu; Li Zhang; Yong Fang Zhang; Wen Xu; Yang Hu; Ying Liu; Jing Bai
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

4.  Possible Involvement of Tissue Plasminogen Activator/Brain-Derived Neurotrophic Factor Pathway in Anti-Depressant Effects of Electroacupuncture in Chronic Unpredictable Mild Stress-Induced Depression in Rats.

Authors:  Tong Luo; Huiling Tian; Hongtao Song; Jun Zhao; Ai Liya; Yumin Fang; Junhui Mou; Zhigang Li; Saiyin Chaoketu
Journal:  Front Psychiatry       Date:  2020-02-20       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.